HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.

Abstract
Idiopathic CD4+ T lymphocytopenia (ICL) is a rare heterogeneous disorder defined by CD4+ T-cell counts below 300 cells/muL in the absence of human immunodeficiency virus (HIV) infection or other known immune deficiency disorders. Here, we report the expansion of immature/transitional B cells in patients with ICL, which is associated with elevated serum levels of IL-7. Both the percentage of immature/transitional B cells and levels of IL-7 were inversely correlated with levels of CD4+ T-cell counts and directly correlated to each other. Further analyses of B cells indicated that, in contrast to the activating effects of HIV disease on mature B cells, the expansion of immature/transitional B cells in patients with ICL occurred at the expense of memory B cells. These findings extend previous reports on primary immunodeficiencies as well as HIV disease by suggesting that CD4+ T-cell lymphopenia has an impact on human B-cell development either directly or indirectly via the associated elevation of IL-7 levels.
AuthorsAngela Malaspina, Susan Moir, Doreen G Chaitt, Catherine A Rehm, Shyam Kottilil, Judith Falloon, Anthony S Fauci
JournalBlood (Blood) Vol. 109 Issue 5 Pg. 2086-8 (Mar 01 2007) ISSN: 0006-4971 [Print] United States
PMID17053062 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Interleukin-7
Topics
  • B-Lymphocytes (metabolism, pathology)
  • Cell Differentiation
  • Humans
  • Interleukin-7 (blood)
  • T-Lymphocytopenia, Idiopathic CD4-Positive (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: